• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血糖控制及早期糖尿病肾病对糖尿病患者尿N-乙酰氨基葡萄糖苷酶(NAG)排泄的影响]

[Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].

作者信息

Sánchez-Hueso M C, Mateo-Caãs J, Zamora-Madaria E

机构信息

Hospital Universitario Virgen Macarena de Sevilla, Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla.

出版信息

An Med Interna. 1995 May;12(5):216-20.

PMID:7669872
Abstract

Plasma glucose, glycated hemoglobin lc (HbAlc), urinary albumin excretion rate (AER) and urinary N-acetyl-glucosaminidase (NAG): creatinine ratio were studied in 100 normotensive diabetic patients with no evidence of overt renal disease and in 45 controls, to find out whether the glycaemic control and incipient nephropathy may influence the urinary excretion of NAG. Twenty-three of the diabetics had microalbuminuria (group II). Group I comprised the 77 diabetics without microalbuminuria. The groups I and II of diabetics were divided into two according to plasma glucose were greater o smaller to 140 mg/dl. The group I of diabetics had greater NAG: creatinine ratio than controls, too (0.41 +/- 0.24 and 0.16 +/- 0.08 mu/mmol creatinine, p < 0.0005); in this group urinary NAG was found to positively correlate with plasma glucose and creatinine (p < 0.0005, r = 0.45). Multiple regression analysis was performed in the whole of diabetics and significant association were identified between urinary NAG excretion and plasma glucose, AER and plasma creatinine (p < 0.0005, r = 0.42). The diabetics with plasma glucose lower to 140 mg/dl had more important correlation NAG: creatinine ratio-AER (p < 0.0001, r = 0.70). It is concluded that measurement of urinary NAG may be of value in the detection of diabetic nephropathy at a potentially reversible stage if the plasma glucose is take into account.

摘要

对100例无明显肾脏疾病证据的血压正常的糖尿病患者及45例对照者的血浆葡萄糖、糖化血红蛋白lc(HbAlc)、尿白蛋白排泄率(AER)和尿N-乙酰氨基葡萄糖苷酶(NAG):肌酐比值进行了研究,以确定血糖控制和早期肾病是否会影响NAG的尿排泄。23例糖尿病患者有微量白蛋白尿(II组)。I组包括77例无微量白蛋白尿的糖尿病患者。糖尿病患者的I组和II组根据血浆葡萄糖大于或小于140mg/dl分为两组。糖尿病患者的I组NAG:肌酐比值也高于对照组(分别为0.41±0.24和0.16±0.08μ/mmol肌酐,p<0.0005);在该组中发现尿NAG与血浆葡萄糖和肌酐呈正相关(p<0.0005,r=0.45)。对所有糖尿病患者进行了多元回归分析,发现尿NAG排泄与血浆葡萄糖、AER和血浆肌酐之间存在显著关联(p<0.0005,r=0.42)。血浆葡萄糖低于140mg/dl的糖尿病患者NAG:肌酐比值与AER的相关性更显著(p<0.0001,r=0.70)。结论是,如果考虑血浆葡萄糖,测定尿NAG可能对在潜在可逆阶段检测糖尿病肾病有价值。

相似文献

1
[Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].[血糖控制及早期糖尿病肾病对糖尿病患者尿N-乙酰氨基葡萄糖苷酶(NAG)排泄的影响]
An Med Interna. 1995 May;12(5):216-20.
2
Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?1型糖尿病患者中β-血小板球蛋白和N-乙酰-β-D-氨基葡萄糖苷酶的尿排泄:早期肾病的潜在指标?
Diabete Metab. 1990 Sep-Oct;16(5):441-7.
3
Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.褪黑素可降低糖尿病大鼠尿液中N-乙酰-β-D-氨基葡萄糖苷酶、白蛋白及肾脏氧化标志物的排泄量。
Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):95-101. doi: 10.1111/j.1440-1681.2006.04330.x.
4
Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.I型糖尿病患者尿N-乙酰-β-D-氨基葡萄糖苷酶活性
Indian Pediatr. 2003 May;40(5):410-4.
5
Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.尿β2-微球蛋白水平及尿N-乙酰-β-D-氨基葡萄糖苷酶活性在非胰岛素依赖型糖尿病肾病早期诊断中的作用
Diabetes Res. 1994;26(3):101-7.
6
Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.2型糖尿病患者中组织蛋白酶B、N-乙酰-β-D-氨基葡萄糖苷酶的尿液活性及蛋白尿情况
Med Sci Monit. 2006 May;12(5):CR210-4.
7
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.2型糖尿病患者血浆及尿液血管内皮生长因子与糖尿病肾病
Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x.
8
Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria.
Clin Nephrol. 1987 Nov;28(5):227-31.
9
[Urinary glycosaminoglycans in patients with incipient diabetic nephropathy].
Nihon Jinzo Gakkai Shi. 1995 Jan;37(1):17-23.
10
[Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].N-乙酰-β-D-氨基葡萄糖苷酶对糖尿病肾病预测的临床评估
Hokkaido Igaku Zasshi. 1992 Mar;67(2):234-46.

引用本文的文献

1
Predictive Potential of Twenty-Two Biochemical Biomarkers for Coronary Artery Disease in Type 2 Diabetes Mellitus.二十二种生化生物标志物对2型糖尿病患者冠状动脉疾病的预测潜力
Int J Endocrinol. 2015;2015:146816. doi: 10.1155/2015/146816. Epub 2015 May 18.
2
Determination of urinary enzymes as a marker of early renal damage in diabetic patients.测定尿酶作为糖尿病患者早期肾损伤的标志物。
J Clin Lab Anal. 2007;21(6):413-7. doi: 10.1002/jcla.20212.
3
Analysis of urinary albumin, transferrin, N-acetyl-beta-D-glucosaminidase and beta2-microglobulin in patients with impaired glucose tolerance.
糖耐量受损患者尿白蛋白、转铁蛋白、N-乙酰-β-D-氨基葡萄糖苷酶和β2-微球蛋白的分析
J Clin Lab Anal. 1998;12(6):351-5. doi: 10.1002/(SICI)1098-2825(1998)12:6&#x0003c;351::AID-JCLA4&#x0003e;3.0.CO;2-7.